Analysis: Strive's SATS Preferred Stock May Achieve Bitcoin Appreciation Through a 15% Dividend Rate
Bitcoin Magazine's analysis suggests that Strive's newly listed SATS perpetual preferred stock, with its 15% fixed dividend rate, is likely to trade above its par value of $100. The article explains that if the market price of SATS reaches $115, Strive could raise capital at an effective financing cost of approximately 13% by issuing new shares. This capital could then be used to purchase Bitcoin, thereby increasing Net Bitcoin Per Share (Net BPS) with each issuance. The analysis posits that SATS's cumulative and fixed dividend characteristics may lead it to be priced in the market at a lower effective yield compared to similar products, which would push up its market price and result in the appreciation of Bitcoin assets.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Oracle, Meta, and SpaceX credit default swaps (CDS) hit all-time highs, as the market anticipates a surge in AI-related bond issuance in Q4.
-
2
Liu Jun, President of Industrial and Commercial Bank of China (ICBC): Commercial Banks Bear Heavier Financial and Legal Responsibilities Than Central Banks in AI Deployment
-
3
Bain Survey: Chinese Consumers Prioritize Technology in Car Purchases, While Europeans and Americans Still Value Price; Western Automakers Face Dual Pressure
-
4
Anthropic pitches AI safety bill that would require judge's permission to block models
-
5
Anthropic reportedly faces a compute shortage as cloud giants view it as a competitor, plans November IPO.
-
6
NextDC's data center project in Australia faces power supply delays due to resident protests, leading to a more than one-third reduction in its FY2027 earnings guidance and a 45% plunge in its stock price.
-
7
Media reports: Amazon Web Services (AWS) has billions of dollars worth of NVIDIA chips backlogged in its warehouses due to power shortages, leading to negative free cash flow.
-
8
Hansoh Pharmaceutical inks up to $15B drug deal with Roche, China's innovative drug out-licensing hits $130B
-
9
King Charles III of the UK praised Oman's peaceful efforts in reopening the Strait of Hormuz.
-
10
U.S. equity index futures rose, boosted by strong earnings reports from AI-related companies.
Markets Today
Recommended Reading


